Moreover, its pathological role in tumorigenesis has been reported through the regulation of cyclin D1 and c-Myc genes in neuroblastoma, gastric cancer and non-Hodgkin lymphoma (42–44). This evidence concerns the gene MYC and neuroblastoma.